BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15775967)

  • 1. Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3.
    Llorca O; Arias-Palomo E; Zugaza JL; Bustelo XR
    EMBO J; 2005 Apr; 24(7):1330-40. PubMed ID: 15775967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity.
    Yabana N; Shibuya M
    Oncogene; 2002 Oct; 21(50):7720-9. PubMed ID: 12400014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes.
    Sachdev P; Zeng L; Wang LH
    J Biol Chem; 2002 May; 277(20):17638-48. PubMed ID: 11884391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation.
    Kato J; Kaziro Y; Satoh T
    Biochem Biophys Res Commun; 2000 Feb; 268(1):141-7. PubMed ID: 10652228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
    Salojin KV; Zhang J; Delovitch TL
    J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.
    Colomba A; Courilleau D; Ramel D; Billadeau DD; Espinos E; Delsol G; Payrastre B; Gaits-Iacovoni F
    Oncogene; 2008 Apr; 27(19):2728-36. PubMed ID: 17998938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation and activation of Vav GTP/GDP exchange activity in antigen receptor-triggered B cells.
    Gulbins E; Langlet C; Baier G; Bonnefoy-Berard N; Herbert E; Altman A; Coggeshall KM
    J Immunol; 1994 Mar; 152(5):2123-9. PubMed ID: 8133029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vav3 is regulated during the cell cycle and effects cell division.
    Fujikawa K; Inoue Y; Sakai M; Koyama Y; Nishi S; Funada R; Alt FW; Swat W
    Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4313-8. PubMed ID: 11917103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
    Heo J; Thapar R; Campbell SL
    Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
    Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
    Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.
    Lyons LS; Burnstein KL
    Mol Endocrinol; 2006 May; 20(5):1061-72. PubMed ID: 16384856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
    Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
    Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
    Adams JM; Houston H; Allen J; Lints T; Harvey R
    Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vav-family proteins in T-cell signalling.
    Tybulewicz VL
    Curr Opin Immunol; 2005 Jun; 17(3):267-74. PubMed ID: 15886116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.
    Trenkle T; McClelland M; Adlkofer K; Welsh J
    Gene; 2000 Mar; 245(1):139-49. PubMed ID: 10713454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The guanine nucleotide exchange factor VAV3 participates in ERBB4-mediated cancer cell migration.
    Ojala VK; Knittle AM; Kirjalainen P; Merilahti JAM; Kortesoja M; Tvorogov D; Vaparanta K; Lin S; Kast J; Pulliainen AT; Kurppa KJ; Elenius K
    J Biol Chem; 2020 Aug; 295(33):11559-11571. PubMed ID: 32561640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration.
    Toumaniantz G; Ferland-McCollough D; Cario-Toumaniantz C; Pacaud P; Loirand G
    Cardiovasc Res; 2010 Apr; 86(1):131-40. PubMed ID: 19969623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
    Movilla N; Dosil M; Zheng Y; Bustelo XR
    Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2.
    Schuebel KE; Movilla N; Rosa JL; Bustelo XR
    EMBO J; 1998 Nov; 17(22):6608-21. PubMed ID: 9822605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.